Boards of Directors approve registry, appropriate use criteria
Following extensive discussion during the strategic planning conference in March, the Boards of Directors took the bold step of authorizing the formation of a clinical data registry for our specialty. The Registry Task Force, chaired by Lisa E. Ishii, MD, MHS, has been directed to produce recommendations to the Boards of Directors regarding the type of registry as well as the vendor that we will select. The Foundation has been actively studying this project for the last 18 months and feels the time to act is now. The formation of a registry carries a multimillion dollar price tag. This “game changing” action will provide many benefits for our Members. A registry will allow direct reporting of quality measures to CMS, thus simplifying this process greatly. In addition, registries can support measure development, inform alternative payment models, assist with maintenance of certification, and demonstrate clinical effectiveness. Participants will have access to their data, which they can use in negotiations with payers. The boards also approved the creation of “appropriate use criteria,” which are an additional guidance tool that can be used in payer negotiations and can be incorporated into a registry. This will help our advocacy efforts when we negotiate on our Members’ behalf regarding national policies. In the upcoming months we will be presenting more detailed information on registries in general and the type of registry that best meets the needs of our Members. We feel this is an exciting opportunity for our specialty that will enable our Members to practice under all changing paradigms of the healthcare delivery system.
Following extensive discussion during the strategic planning conference in March, the Boards of Directors took the bold step of authorizing the formation of a clinical data registry for our specialty. The Registry Task Force, chaired by Lisa E. Ishii, MD, MHS, has been directed to produce recommendations to the Boards of Directors regarding the type of registry as well as the vendor that we will select. The Foundation has been actively studying this project for the last 18 months and feels the time to act is now. The formation of a registry carries a multimillion dollar price tag.
This “game changing” action will provide many benefits for our Members. A registry will allow direct reporting of quality measures to CMS, thus simplifying this process greatly. In addition, registries can support measure development, inform alternative payment models, assist with maintenance of certification, and demonstrate clinical effectiveness. Participants will have access to their data, which they can use in negotiations with payers. The boards also approved the creation of “appropriate use criteria,” which are an additional guidance tool that can be used in payer negotiations and can be incorporated into a registry. This will help our advocacy efforts when we negotiate on our Members’ behalf regarding national policies.
In the upcoming months we will be presenting more detailed information on registries in general and the type of registry that best meets the needs of our Members. We feel this is an exciting opportunity for our specialty that will enable our Members to practice under all changing paradigms of the healthcare delivery system.